Glenmark Pharmaceuticals consolidated net profit rises 132.47% in the June 2020 quarter
Sales rise 1.12% to Rs 2309.28 crore
Net profit of Glenmark Pharmaceuticals rose 132.47% to Rs 254.04 crore in the quarter ended June 2020 as against Rs 109.28 crore during the previous quarter ended June 2019. Sales rose 1.12% to Rs 2309.28 crore in the quarter ended June 2020 as against Rs 2283.60 crore during the previous quarter ended June 2019. ParticularsQuarter EndedJun. 2020Jun. 2019% Var.Sales2309.282283.60 1 OPM %20.7014.97 -PBDT442.84250.57 77 PBT329.62159.84 106 NP254.04109.28 132Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Aug 17 2020 | 8:23 AM IST